Molecular Test Panel Edit Alert

NOTE: This message is for Palmetto only and the effective date is 7/1/2015.

Palmetto considers the performance of multiple molecular biomarkers ordered together, regardless of whether the test requisition lists the tests as a panel or individually, and completed on a single sample as a panel of tests. Therefore, each panel should be registered and billed with a single CPT code and a unique MolDX identifier. Based on data analysis of MolDX claims, labs are submitting multiple biomarker ‘panels’ as individual tests similar to the submission of the previous stacking codes. Effective November 17, 2014 labs should start to register all panels and obtain a unique MolDX identifier for each panel. Effective November 17, 2014, Palmetto GBA will start lab notification. Labs that have submitted panel test claims will receive a list of MolDX IDs that require panel registration. Each lab will be given 30 days from the receipt of the list to correct test registration. Effective 1/1/15, MolDX will set edits to reject tests performed as panels and registered and submitted with a CPT code for each biomarker in the panel.